title: Provider specialty and atrial fibrillation treatment strategies in United States community practice: findings from the ORBIT-AF registry.
abstract: BACKGROUND
  The prevalence of atrial fibrillation (AF) continues to increase; however, there are limited data describing the division of care among practitioners in the community and whether care differs depending on provider specialty.
  
  
  RESULTS
  Using the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF) Registry, we described patient characteristics and AF management strategies in ambulatory clinic practice settings, including electrophysiology (EP), general cardiology, and primary care. A total of 10 097 patients were included; of these, 1544 (15.3%) were cared for by an EP provider, 6584 (65.2%) by a cardiology provider, and 1969 (19.5%) by an internal medicine/primary care provider. Compared with those patients who were cared for by cardiologists or internal medicine/primary care providers, patients cared for by EP providers were younger (median age, 73 years [interquartile range, IQR, 64, 80 years, Q1, Q3] versus 75 years [IQR, 67, 82 years] for cardiology and versus 76 years [IQR, 68, 82 years] for primary care). Compared with cardiology and internal medicine/primary care providers, EP providers used rhythm control (versus rate control) management more often (44.2% versus 29.7% and 28.8%, respectively, P<0.0001; adjusted odds ratio [OR] EP versus cardiology, 1.66 [95% confidence interval, CI, 1.05 to 2.61]; adjusted OR for internal medicine/primary care versus cardiology, 0.91 [95% CI, 0.65 to 1.26]). Use of oral anticoagulant therapy was high across all providers, although it was higher for cardiology and EP providers (overall, 76.1%; P=0.02 for difference between groups).
  
  
  CONCLUSIONS
  Our data demonstrate important differences between provider specialties, the demographics of the AF patient population treated, and treatment strategies-particularly for rhythm control and anticoagulation therapy.
authors.affiliation: Duke Clinical Research Institute, Duke University Medical Center, Durham, NC.
authors.forename: Emil L
authors.initials: EL
authors.lastname: Fosbol
authors.forename: DaJuanicia N
authors.initials: DN
authors.lastname: Holmes
authors.forename: Jonathan P
authors.initials: JP
authors.lastname: Piccini
authors.forename: Laine
authors.initials: L
authors.lastname: Thomas
authors.forename: James A
authors.initials: JA
authors.lastname: Reiffel
authors.forename: Roger M
authors.initials: RM
authors.lastname: Mills
authors.forename: Peter
authors.initials: P
authors.lastname: Kowey
authors.forename: Kenneth
authors.initials: K
authors.lastname: Mahaffey
authors.forename: Bernard J
authors.initials: BJ
authors.lastname: Gersh
authors.forename: Eric D
authors.initials: ED
authors.lastname: Peterson
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000553:Ambulatory Care; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D002309:Cardiology; D003153:Community Health Services / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D015994:Incidence; D007388:Internal Medicine; D008297:Male; D008511:Medicine / Q000706:statistics & numerical data; D008875:Middle Aged; D010820:Physicians / Q000706:statistics & numerical data; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data; D015995:Prevalence; D011320:Primary Health Care; D011446:Prospective Studies; D012042:Registries; D014481:United States / Q000453:epidemiology
chemical_list: D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants
keywords: ORBIT‐AF; antithrombotic therapy; atrial fibrillation; outpatient; provider; specialty